The term "dyslipidemia risk 3" is not a separate diagnosis in international disease classifications. In Russian-language clinical practice, "risk 3" typically refers to dyslipidemia in individuals with high cardiovascular risk, meaning a significant likelihood of myocardial infarction, stroke, peripheral artery disease, or other atherosclerotic complications in the coming years.